Sun Pharma Shares Tumble Nearly 6% Following Q1 Earnings Decline

Sun Pharmaceutical Industries Ltd saw its shares plunge nearly 6% on Friday, extending losses after reporting a 20% year-on-year drop in consolidated net profit for Q1 2025. The stock closed at ₹1,608.30 on the BSE, marking a 5.7% decline, while NSE recorded a 5.78% fall to ₹1,608.

The Mumbai-based drugmaker's net profit slid to ₹2,279 crore from ₹2,836 crore in the year-ago period, though adjusted profit excluding exceptional items ROSE 6% to ₹2,996 crore. Total income showed resilience, climbing to ₹14,316 crore from ₹13,185 crore in the comparable quarter.

Thursday's earnings release had already triggered a 2% selloff, with the dual-listed shares continuing their descent as investors digested the mixed financial performance. The regulatory filing revealed underlying operational growth masked by one-time items.